Some clinicians recommend microdosing tirzepatide as a maintenance strategy after achieving target weight
Can Correcting B12 Deficiency Reverse Hair Loss
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management (marketed as Zepbound)
Symptoms that are severe, that involve the chest or breathing, or that last more than a few days are not normal and should be checked by a doctor
(Outlines contraindications for niacin therapy, including active peptic ulcer disease, active liver disease with elevated enzymes, hypersensitivity to niacin, and arterial bleeding, as well as monitoring recommendations for blood pressure, glucose, uric acid, etc., due to niacins systemic effects)
Most people just know by the way they feel